On 9/17/24, Capricor Therapeutics Inc (NASDAQ: CAPR) stock enjoyed a major increase of 15.2%, closing at $5.08. Moreover, this advance was accompanied by exceptionally high trading volume at 516% of normal. The stock has risen 21.0% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, CAPR is expected to continue to be Value Creation neutral.
Capricor Therapeutics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Capricor Therapeutics has a poor Power Rating of 27 and a very low Appreciation Score of 5, producing the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment